Current Issues of Hereditary Thrombophilia in the «Woman- Placenta-Fetus» System

Thrombophilia is a heterogeneous group of inherited and acquired diseases and syndromes characterized by increased blood clotting and a high risk of thromboembolic complications. Thrombophilia is not a disease in the generally accepted sense, since it has no clinical manifestations until the first thrombosis, which complicates its diagnosis. At the same time, thromboses make a significant contribution to the overall morbidity and mortality in children of all age groups. Currently, many genetic polymorphisms have been identified that increase the predisposition to thrombosis, including mutations of factor V (Leiden mutation) and prothrombin, as well as polymorphisms of the genes of the blood coagulation system and folate cycle. Risk factors for the development of thrombotic complications also include deficiency of proteins C and S and lack of antithrombin III. Newborns from mothers with hereditary thrombophilia have a significantly increased risk of fetal hypoxia and various pathological conditions and diseases. The presence and combination of various genetic markers of thrombophilia leads to the development of a hypercoagulable state, which increases the risk of thrombohemorrhagic complications. Diagnosis of thrombophilia includes, first of all, the determination of thrombogenic risk factors: permanent (genetic and/or clinical) and temporary (clinical and/or laboratory). The article presents the main genetic markers of thrombophilia, the mechanisms of its development and diagnostic methods.

1. Zotova I.V., Zateyshchikov D.A. Hereditary thrombophilia and venous thromboembolic complications: testing rules in clinical practice. Russian Journal of Cardiology. 2020; 25(3S):4024. (In Russ.) DOI:10.15829/1560-4071-2020-4024

2. Momot A.P., Nikolaeva M.G. Genetic thrombophilia and gestational complications. Bulletin of Hematology. 2020; 4:22—27. (In Russ.) DOI:10.30629/0023-2149-2021-99-1-15-20

3. Melnikov A.P., Kashchuk M.G., Akhvlediani K.N., Bokarev I.N. Thrombophilia in obstetric practice. Clinical Medicine. 2021; 99(1):15—20. (In Russ.) DOI: 10.30629/0023-2149-2021-99-1-15-20

4. Rogova A.S., Ilyina A.Ya., Mishchenko A.L., Levchenko L.A., Shabliy M.V., et al. Modern approaches to assessing the state of the hemostasis system in children with congenital thrombogenic risk factors. Pediatrician Practice. 2023; 4:30—38. (In Russ.)

5. Nesterova E.A., Putilova N.V., Tretyakova T.B., Pestryaeva L.A. The role of genetically determined pathology of fetal hemostasis in the formation of severe forms of placental insufficiency. Obstetrics and Gynecology. 2017; 9:58— 62. (In Russ.) DOI:10.18565/aig.2017.9.58-62

6. Ciurea EL, Berceanu C, Voicu NL, Pirnoiu D, Berceanu S, Stepan AE. Morphological Survey of Placenta in Trombophilia Related Hypoperfusion of Maternal-Fetal Blood Flow. Curr Health Sci J. 2018 Jan-Mar; 44(1):85—91. DOI: 10.12865/CHSJ.44.01.15.

7. Khizroeva, J., Makatsariya, A., Vorobev, A., Bitsadze, V. et al. The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis. International Journal of Molecular Sciences. 2023; 24(18). DOI:10.3390/ijms241813864

8. Makatsariya A, Bitsadze V, Khizroeva J, Vorobev A, Makatsariya N, Egorova E, Mischenko A, Mashkova T, Antonova A. Neonatal thrombosis. J Matern Fetal Neonatal Med. 2022 Mar; 35(6):1169—1177. doi: 10.1080/14767058.2020.1743668.

9. Robinson V, Achey MA, Nag UP, Reed CR, Pahl KS et al Thrombosis in infants in the neonatal intensive care unit: Analysis of a large national database. J Thromb Haemost. 2021;19(2):400—407. DOI: 10.1111/jth.15144

10. Nikolaeva M. G., Momot A. P., Mamaev A. N., Khorev N. G. et al. Thrombotic events in rare forms of genetic thrombophilia. Thrombosis, Нemostasis and Rheology. 2020; (4):87—94. (In Russ.) DOI: 10.25555/THR.2020.4.0950

11. Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020 May; 49(4):618—629. DOI:10.1007/s11239-020-02090-y

12. Athar A, Kashyap P, Khan S, Sattar RSA, Khan SA, Prasad S, Husain SA, Parveen F. Genetic landscape of thrombophilia in recurrent miscarriages. Obstet Gynecol Sci. 2024 Sep; 67(5):435—448. DOI:10.5468/ogs.22084

13. García-Alfaro, M.D.; Pérez-Nuñez, M.I.; Amigo, M.T.; Arbona, C.; Ballesteros, M.Á.; González-Lamuño, D. PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg—Calvé—Perthes Disease. Children. 2021; 8:614. DOI:10.3390/children8070614

14. Graydon JS, Claudio K, Baker S, Kocherla M, Ferreira M, Roche-Lima A, Rodríguez-Maldonado J, Duconge J, Ruaño G. Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations. Biomark Med. 2019 Jun; 13(8):649—661. DOI: 10.2217/bmm-2018-0392.

15. Shibeeb S, Al-Rayashi N, Shams N, Hadvan T et al. Factor V Leiden (R506Q), Prothrombin G20210A, and MTHFR C677T Variants and Thrombophilia in Qatar Biobank Participants: A Case Control Study. Pathophysiology. 2024, Oct21; 31(4):608—620. DOI:10.3390/pathophysiology31040044

16. Strozenko L.A. Primary Thromboprophylaxis in Adolescents Based on the Identification and Modification of Persistent and Temporary Thrombogenic Risk Factor: Abstract --- MD. Moscow, 2014. (In Russ.)

17. Shikhbabaeva DI, Polushkina LB, Shuvaev VA, Martynkevich IS, Kapustin SI et al. Genetic markers of hereditary thrombophilia and the risk of thrombotic complications in patients with true polycythemia. Clinical Оncohematology. Fundamental Research and Clinical Practice. 2017; 10(1):85—92. (In Russ.) DOI:10.21320/2500-2139-2017-10-1-85-92

18. Belousova T.V., Leonova A.A., Plyushkin V.A. Risk factors for the development of thrombotic complications in children who suffered critical conditions at birth. Pediatrics. Consilium Medicum. 2017; (3):95—100. (In Russ.)

19. Fanaroff A.A., Martin R.J. Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 12th ed. 2025, Vol. 2.

20. Martynov A.A., A.Ya. Ilyina, A.L. Mishchenko, M.V. Shabliy. Modern aspects of hemostasis diagnostics in children with thrombohemorrhagic complications. Pediatrician Practice. 2024; 3:53—60. (In Russ.)

21. AbdelAziz N.H. et al. Impact of Thrombophilia on the Risk of Hypoxic— Ischemic Encephalopathy in Newborns. Clin Appl Thromb Hemost. 2015; 21(8):729—35. DOI: 10.1177/1076029615607302

22. Ilyina A.Ya., Mishchenko A.L., Martynov A.A., Levchenko L.A., Shabliy M.V., Akhalova E.A., Rogova A.S., Solovieva I.V. Assessment of the health status of newborns with venous thrombosis. Thrombosis, Hemostasis and Rheology. 2023; (3):19—27. (In Russ.) DOI:10.25555/THR.2023.3.1065.

23. Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta. 2015 Aug; 36(8):960—6. DOI: 10.1016/j.placenta.2015.05.016.

24. Pankov EA, Papayan KA, Kapustin SI, Savenkova ND Features of the distribution of polymorphic variants of genes associated with thrombophilia and arterial hypertension in children with hemolytic uremic syndrome. Nephrology. 2020; 24(3):90—94. (In Russ.) DOI:10.36485/1561-6274-2020-24-3-90-94

25. Gülhan B, Özaltın F. Hemolytic Uremic Syndrome in Children. Turk Arch Pediatr. 2021 Sep; 56(5):415—422. DOI: 10.5152/TurkArchPediatr.

26. Alconcher LF, Lucarelli LI, Bronfen S. Long-term kidney outcomes in non-dialyzed children with Shiga-toxin Escherichia coli associated hemolytic uremic syndrome. Pediatr Nephrol. 2023 Jul; 38(7):2131—2136. DOI: 10.1007/s00467-022-05851-4.

27. Clinical guidelines Venous complications during pregnancy and the postpartum period. Obstetric thromboembolism. Russian Society of Obstetricians and Gynecologists, 2022. (In Russ.)

28. Clinical guidelines. Habitual miscarriage. Russian Society of Obstetricians and Gynecologists, 2022. (In Russ.)

29. Clinical guidelines. Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period. Russian Society of Obstetricians and Gynecologists, 2021. (In Russ.)

30. Federal Clinical Guidelines of the National Society of Pediatric Hematologists and Oncologists on the Diagnosis, Prevention, and Treatment of Thrombosis in Children and Adolescents. Moscow, 2015. ed. Rumyantsev A.G., Maschan A.A., Zharkov P.A., Svirin P.V. (In Russ.)

31. Van Cott EM, Orlando C, Moore GW, Cooper PC et al; Subcommittee on Plasma Coagulation Inhibitors. Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jan; 18(1):17—22. DOI:10.1111/jth.14648.

32. Papayan L P. , O.G. Golovina, O.Yu. Matvienko, N.N. Silina. Hereditary thrombophilias (lecture). Bulletin of Рematology.. 2023; 19(3):52—62. (In Russ.)

33. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017 Sep 21; 377(12):1177—1187. DOI:10.1056/NEJMra1700365.

34. Gupta A, Tun AM, Gupta K, et al. Protein S Deficiency. [Updated 2022 Dec 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;

35. Mishchenko A.L., Khamani N.M., Stuleva N.S. Diagnostics of hemostasis disorders in newborns. Obstetrics, Gynecology and Reproduction. 2016; 1: 62—73. (In Russ.)

36. Kripakova V.V., Zolotavina M.L., Bodovets G.N. Changes in hemostasis system parameters in pregnant women with thrombophilia. New Impulses of Development: Issues of Scientific Research. 2021; 2 20—31. (In Russ.)